Korro Bio
(NASDAQ) KRRO
Korro Bio Financials at a Glance
Market Cap
$154.61M
Revenue (TTM)
$3.84M
Net Income (TTM)
-$113.50M
EPS (TTM)
-$11.68
P/E Ratio
-0.92
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$10.63
Volume
115,171.43
Open
$10.82
Price
$10.63
Volume
115,171.43
Open
$10.82
Previous Close
$10.59
Daily Range
$10.52 - $11.11
52-Week Range
$5.20 - $55.89
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$10.63
Volume
115,171.43
Open
$10.82
Previous Close
$10.59
Daily Range
$10.52 - $11.11
52-Week Range
$5.20 - $55.89
Estimated Earnings Date
Aug 11, 2026
KRRO News
KRRO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Korro Bio
Industry
Biotechnology
Sector
Health CareEmployees
49
CEO
Ram Aiyar, PhD, MBA
Website
www.korrobio.comHeadquarters
Cambridge, MA 02139-1562, US
KRRO Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
-22%
Net Income Margin
-30%
Return on Equity
-88%
Return on Capital
-49%
Return on Assets
-62%
Earnings Yield
-1.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$154.61M
Shares Outstanding
14.42M
Volume
115.17K
Avg. Volume
178.44K
Financials (TTM)
Gross Profit
$2.11M
Operating Income
-$87.34M
EBITDA
-$83.06M
Operating Cash Flow
-$78.56M
Capital Expenditure
-$518.00K
Free Cash Flow
-$79.08M
Cash & ST Invst.
$75.16M
Total Debt
$43.49M
Korro Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$380.00K
-114.9%
Gross Margin
0.00%
N/A
Market Cap
$154.61M
N/A
Market Cap/Employee
$1.38M
N/A
Employees
112
N/A
Net Income
-$19.63M
+16.1%
EBITDA
-$20.06M
+15.7%
Quarterly Fundamentals
Net Cash
$71.09M
+1.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$40.08M
-6.5%
Short Term Debt
$2.80M
+21.5%
Return on Assets
-61.81%
N/A
Return on Invested Capital
-49.02%
N/A
Free Cash Flow
-$16.10M
+34.5%
Operating Cash Flow
-$16.07M
+34.3%